Canada Markets closed

Elevance Health, Inc. (ELV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
472.12+2.42 (+0.52%)
At close: 01:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3549.52
52 Week Low 3440.02
50-Day Moving Average 3477.96
200-Day Moving Average 3487.29

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 31.15M
Shares Outstanding 5238.83M
Implied Shares Outstanding 6N/A
Float 8240.81M
% Held by Insiders 10.22%
% Held by Institutions 192.83%
Shares Short (Jan 30, 2023) 41.68M
Short Ratio (Jan 30, 2023) 41.32
Short % of Float (Jan 30, 2023) 40.70%
Short % of Shares Outstanding (Jan 30, 2023) 40.70%
Shares Short (prior month Dec 29, 2022) 41.86M

Dividends & Splits

Forward Annual Dividend Rate 45.92
Forward Annual Dividend Yield 41.22%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 41.12
Payout Ratio 420.64%
Dividend Date 3Mar 23, 2023
Ex-Dividend Date 4Mar 08, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022

Profitability

Profit Margin 3.85%
Operating Margin (ttm)5.53%

Management Effectiveness

Return on Assets (ttm)5.41%
Return on Equity (ttm)16.60%

Income Statement

Revenue (ttm)156.59B
Revenue Per Share (ttm)644.96
Quarterly Revenue Growth (yoy)9.10%
Gross Profit (ttm)40.11B
EBITDA 10.33B
Net Income Avi to Common (ttm)6.02B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-16.50%

Balance Sheet

Total Cash (mrq)34.29B
Total Cash Per Share (mrq)142.17
Total Debt (mrq)24.11B
Total Debt/Equity (mrq)66.26
Current Ratio (mrq)1.40
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)8.4B
Levered Free Cash Flow (ttm)8.73B